As of 2026-04-07, the Relative Valuation of Veracyte Inc (VCYT) is 22.62 USD. This relative valuation is based on P/E multiples. With the latest stock price at 32.32 USD, the upside of Veracyte Inc based on Relative Valuation is -30.0%.
The range of the Relative Valuation is 19.37 - 27.46 USD.
| Range | Selected | |
| Trailing P/E multiples | 23.2x - 28.8x | 25.9x |
| Forward P/E multiples | 21.4x - 28.2x | 24.2x |
| Fair Price | 19.37 - 27.46 | 22.62 |
| Upside | -40.1% - -15.0% | -30.0% |
| Date | P/E |
| 2026-04-06 | 38.70 |
| 2026-04-02 | 38.62 |
| 2026-04-01 | 38.80 |
| 2026-03-31 | 38.57 |
| 2026-03-30 | 36.45 |
| 2026-03-27 | 35.94 |
| 2026-03-26 | 39.28 |
| 2026-03-25 | 39.27 |
| 2026-03-24 | 39.45 |
| 2026-03-23 | 40.17 |
| 2026-03-20 | 38.13 |
| 2026-03-19 | 39.26 |
| 2026-03-18 | 39.85 |
| 2026-03-17 | 40.09 |
| 2026-03-16 | 39.42 |
| 2026-03-13 | 38.48 |
| 2026-03-12 | 37.04 |
| 2026-03-11 | 38.87 |
| 2026-03-10 | 39.26 |
| 2026-03-09 | 39.96 |
| 2026-03-06 | 40.54 |
| 2026-03-05 | 41.53 |
| 2026-03-04 | 43.43 |
| 2026-03-03 | 42.01 |
| 2026-03-02 | 43.12 |
| 2026-02-27 | 43.82 |
| 2026-02-26 | 46.40 |
| 2026-02-25 | 42.78 |
| 2026-02-24 | 42.74 |
| 2026-02-23 | 42.81 |
| 2026-02-20 | 42.67 |
| 2026-02-19 | 43.45 |
| 2026-02-18 | 43.84 |
| 2026-02-17 | 43.15 |
| 2026-02-13 | 42.84 |
| 2026-02-12 | 42.09 |
| 2026-02-11 | 43.10 |
| 2026-02-10 | 44.34 |
| 2026-02-09 | 43.99 |
| 2026-02-06 | 43.34 |
| 2026-02-05 | 41.75 |
| 2026-02-04 | 43.23 |
| 2026-02-03 | 45.19 |
| 2026-02-02 | 45.70 |
| 2026-01-30 | 45.60 |
| 2026-01-29 | 46.39 |
| 2026-01-28 | 46.08 |
| 2026-01-27 | 47.66 |
| 2026-01-26 | 48.58 |
| 2026-01-23 | 50.62 |